# Dataset 1
- **First author:** Lestat R. Ali  
- **Corresponding author(s):** Stephanie K. Dougan  
- **DOI:** [10.1158/1078-0432.CCR-23-1444](https://doi.org/10.1158/1078-0432.CCR-23-1444)  
- **Cancer type:** Pancreatic Ductal Adenocarcinoma (PDAC)  
- **Treatments:** Anti-PD-1 + Chemoradiation (CRT), CRT only  
- **Unique patients:** 3  
- **Sample types:** Blood, Tumor  
- **Timepoints:** Pre-Infusion, Post-Infusion 
- The dataset includes **gene expression**, **TCR**, and **metadata** files.

# Dataset 2
- **First author:** Ayse Bassez  
- **Corresponding author(s):** Diether Lambrechts, Ann Smeets 
- **DOI:** [https://doi.org/10.1038/s41591-021-01323-8](https://doi.org/10.1038/s41591-021-01323-8)
- **Cancer type:** Hormone receptor-positive or triple-negative breast cancer (TNBC)
- **Treatments:** Anti-PD-1 (Pembrolizumab) ± Neoadjuvant chemotherapy
- **Unique patients:** 42
- **Sample types:** Tumor
- **Timepoints:** Pre-Infusion, Post-Infusion
- The dataset includes gene expression, TCR, and metadata files.

# Dataset 3
- **First author:** Justina X. Caushi
- **Corresponding author(s):** Srinivasan Yegnasubramanian, Hongkai Ji, Drew M. Pardoll or Kellie N. Smith.
- **DOI:** [https://doi.org/10.1038/s41586-021-03752-4](https://doi.org/10.1038/s41586-021-03752-4)
- **Cancer type:** Non-small cell lung cancer (NSCLC)
- **Treatments:** Neoadjuvant anti–PD-1 therapy (Nivolumab)
- **Unique patients:** 16
- **Sample types:** Tumor, Blood, Normal Adjacent Tissue, Lymph Nodes
- **Timepoints:** 4 weeks post-treatment at time of surgery
- The dataset includes gene expression, TCR, and metadata files.

# Dataset 4
- **First author:** Ryan D. Chow
- **Corresponding author(s):** Ryan D. Chow, Eric Song, Alessandro D. Santin
- **DOI:** [https://doi.org/10.1158/2159-8290.CD-22-0686](https://doi.org/10.1158/2159-8290.CD-22-0686)
- **Cancer type:** Mismatch-repair–deficient (MMRd) endometrial carcinoma
- **Treatments:** Anti-PD-1 (Pembrolizumab)
- **Unique patients:** 24
- **Sample types:** Peripheral blood (PBMCs); tumor (bulk TCR used for tumor-reactive clone identification)
- **Timepoints:** Pre-treatment, On-treatment (Day 21, Day 42)
- The dataset includes gene expression, TCR, and metadata files.


